Swiss drugmaker Roche Holding AG (RHHBY.PK) reported Wednesday that its fiscal 2014 net income, on IFRS basis, declined 16 percent to 9.54 billion Swiss francs from last year's 11.37 billion francs.
The company said its net income was negatively impacted by debt restructuring, impairments and restructuring costs in 2014.
Core net income was 12.533 billion francs or 14.29 francs per share, compared to last year's 12.526 billion francs or 14.27 francs per share.
Group sales went up 1 percent to 47.46 billion francs from 46.78 billion francs a year ago. Sales grew 5 percent at constant exchange rates.
Further, the company said its Board proposed dividend increase of 3 percent to 8.00 Swiss francs, representing 28th consecutive year of dividend growth.
Looking ahead for fiscal 2015, the company expects sales to grow low-to mid-single digit, at constant exchange rates. Core earnings per share is targeted to grow at constant exchange rates ahead of sales.
Roche added that it expects to further increase its dividend in Swiss francs.
For comments and feedback contact: editorial@rttnews.com
Business News